Adam Lawrence was appointed Chief Executive on 1 January 2011.
Adam is an experienced Executive. He began his professional career as a Chartered Accountant with Price Waterhouse. Since 1995, he held a number of senior positions with Catalent Pharmaceuticals for businesses located across Asia Pacific, Europe and the US. He was Vice President Finance for the Sterile Technologies division before leaving in 2008 to join the Royal Mint as Director of Finance.
Adam was appointed as Chief Operating Officer in May 2010 and holds an MBA from Monash Mt Eliza Business School.